Company Filing History:
Years Active: 2000-2001
Title: Innovations in Cardiac Procedures by Eric E. Solien
Introduction
Eric E. Solien is an accomplished inventor based in New Brighton, Minnesota, known for his significant contributions to cardiac medical procedures. With a total of three patents to his name, Solien's work focuses on enhancing blood flow mechanisms through innovative surgical techniques.
Latest Patents
Among his most notable inventions is the patent for a Transmyocardial implant procedure. This groundbreaking method creates a blood flow path from a heart chamber to a coronary vessel located on the exterior surface of the heart wall. The procedure involves a hollow conduit that encompasses both a vessel portion and a myocardial portion. The vessel portion is designed with an open leading end that can be inserted into the coronary vessel. Meanwhile, the myocardial portion has a leading end that extends through the thickness of the heart wall, safely positioning within the heart wall while allowing the open leading end to protrude into the heart chamber. Initially, blood flow through the conduit from the heart chamber is partially blocked, but once the leading end of the vessel portion is correctly placed within the coronary vessel, blood flow from the heart chamber into the vessel is subsequently enabled.
Career Highlights
Eric E. Solien has made remarkable strides in the medical field, particularly through his role at HeartStent Corporation. His innovative spirit and dedication to finding solutions for complex cardiac conditions have positioned him as a valuable resource within the medical community.
Collaborations
Throughout his career, Solien has collaborated with esteemed colleagues such as Guy P. Vanney and Thomas L. Odland. These collaborations have allowed for a multidisciplinary approach to solving some of the most pressing challenges in cardiac health.
Conclusion
In summary, Eric E. Solien stands out as a pivotal figure in cardiac innovation. His contributions, particularly through the Transmyocardial implant procedure, demonstrate his commitment to enhancing patient outcomes and advancing the field of cardiac medicine. The ongoing impact of his work at HeartStent Corporation, alongside his collaborations, underscores the importance of teamwork in driving innovation within the medical sector.